Package Leaflet: Information for the User
Pregabalin Aristo20 mg/ml oral solution EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of thepackage leaflet
Pregabalin Aristo belongs to a group of medicines used to treat epilepsy, neuropathic pain, and generalized anxiety disorder (GAD) in adults.
Peripheral and central neuropathic pain:pregabalin is used to treat long-lasting pain caused by damage to the nerves. There are several diseases that can cause peripheral neuropathic pain, such as diabetes or herpes. The feeling of pain can be described as heat, burning, throbbing, shooting, stabbing, sharp, spasms, continuous, tingling, numbness, and a feeling of pins and needles. Peripheral and central neuropathic pain may also be associated with mood changes, sleep disturbances, fatigue (tiredness), and can have an impact on physical and social activity and overall quality of life.
Epilepsy:pregabalin is used in the treatment of certain types of epilepsy (partial seizures with or without secondary generalization) in adults. Your doctor will prescribe pregabalin for you to treat epilepsy when your current treatment is not controlling the condition. You should take pregabalin in addition to your current treatment. This medicine should not be taken on its own, but should always be used in combination with other antiepileptic treatments.
Generalized anxiety disorder:pregabalin is used in the treatment of generalized anxiety disorder (GAD). The symptoms of GAD are excessive and prolonged worry and anxiety that are difficult to control. GAD can also cause restlessness or a feeling of being "on edge" or nervous, feeling tired easily, having difficulty concentrating or having a blank mind, irritability, muscle tension, or sleep disturbances. This is different from everyday stress and strain.
Do not takePregabalin Aristo
If you are allergic to pregabalin or any of the other ingredients of this medicine (listed in section 6).
Warnings and precautions
Consult your doctor or pharmacist before taking this medicine.
Dependence
Some people may become dependent on pregabalin (need to keep taking the medicine). They may have withdrawal effects when they stop using pregabalin (see section 3, “How to take Pregabalin Aristo”and “If you stop taking pregabalin”). If you are concerned that you may become dependent on pregabalin, it is important that you consult your doctor.
If you notice any of the following signs while taking pregabalin, it could be a sign that you have become dependent:
If you notice any of these signs, talk to your doctor to discuss the best care plan for you, including when it is appropriate to stop treatment and how to do it safely.
Children and adolescents
The safety and efficacy in children and adolescents (under 18 years) have not been established, so pregabalin should not be used in this age group.
Other medicines and pregabalin
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Pregabalin and certain medicines can affect each other (interact). When pregabalin is used with certain sedative medicines (including opioids), these effects may be increased, which can lead to respiratory failure, coma, and death. The degree of dizziness, somnolence, and decreased concentration may increase if pregabalin is taken with other medicines that contain:
Oxicodone – (used as a painkiller)
Lorazepam – (used to treat anxiety)
Alcohol
This medicine can be taken with oral contraceptives.
Taking pregabalin with food, drinks, and alcohol
Pregabalin can be taken with or without food.
It is advised not to drink alcohol during treatment with this medicine.
Pregnancy, breastfeeding, and fertility
Do not take pregabalin during pregnancy or breastfeeding, unless your doctor has told you to do so. The use of pregabalin during the first 3 months of pregnancy may cause congenital malformations in the fetus that require medical treatment. In a study that reviewed data from women in Nordic countries who took pregabalin during the first 3 months of pregnancy, 6 babies out of 100 had such congenital malformations. This compares with 4 babies out of 100 born to women not treated with pregabalin in the study. There have been reports of malformations of the face (clefts), eyes, nervous system (including the brain), kidneys, and genitals.
An effective contraceptive method should be used in women of childbearing age. If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Driving and using machines
Pregabalin may cause symptoms such as dizziness, somnolence, and decreased concentration. These effects, as well as the underlying disease, may impair your ability to drive vehicles or operate machines. Therefore, you should not drive, operate machinery, or engage in other potentially hazardous activities until you know whether this medicine affects your ability to perform these activities.
This medicine contains methylparahydroxybenzoate (E-218)
It may cause allergic reactions (possibly delayed) because it contains methylparahydroxybenzoate (E-218).
This medicine contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per ml; this is essentially “sodium-free”.
Follow exactly the instructions for administration of this medicine given by your doctor. If you are unsure, consult your doctor or pharmacist again. Do not take more medicine than prescribed.
Your doctor will determine the dose that is right for you.
Peripheral and central neuropathic pain, epilepsy, or generalized anxiety disorder:
If you think the effect of this medicine is too strong or too weak, tell your doctor or pharmacist.
If you are an elderly patient (over 65 years old), you should take this medicine normally, unless you have kidney problems.
Your doctor may prescribe a different dosing regimen and/or different doses if you have kidney problems.
Continue taking this medicine until your doctor tells you to stop.
Administration:
Instructions for use
Pregabalin is for oral use only.
Note:Steps 4-7 may need to be repeated up to three times to obtain the total dose (Table 1).
[For example, a dose of 150 mg (7.5 ml) will require withdrawing the volume from the bottle twice to reach the complete dose. Using the syringe, withdraw 5 ml first, empty the contents directly into the mouth, and then take another 2.5 ml, emptying the remaining contents into the mouth.]
Table 1. Volume to be extracted with the syringe to obtain the prescribed dose of pregabalin
Pregabalin dose (mg) | Total volume of the solution (ml) | First extraction with the syringe (ml) | Second extraction with the syringe (ml) | Third extraction with the syringe (ml) |
25 | 1.25 | 1.25 | Not required | Not required |
50 | 2.5 | 2.5 | Not required | Not required |
75 | 3.75 | 3.75 | Not required | Not required |
100 | 5 | 5 | Not required | Not required |
150 | 7.5 | 5 | 2.5 | Not required |
200 | 10 | 5 | 5 | Not required |
225 | 11.25 | 5 | 5 | 1.25 |
300 | 15 | 5 | 5 | 5 |
If you take more Pregabalin Aristo than you should
Call your doctor or go to the nearest emergency room immediately. Take the package or bottle of the oral solution with you. As a result of taking more medicine than you should, you may feel drowsy, confused, agitated, or restless. There have also been reports of seizures and unconsciousness (coma).
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Pregabalin Aristo
It is important that you take the Pregabalin Aristo oral solution regularly at the same time every day. If you forget to take a dose, take it as soon as you remember, unless it is time for the next dose. In that case, continue with the next dose as normal. Do not take a double dose to make up for forgotten doses.
If you stop taking Pregabalin Aristo
Do not stop taking this medicine suddenly. If you want to stop taking this medicine, talk to your doctor first. If you are going to stop treatment, it should be done gradually over a minimum of one week.
Once you have finished treatment with this medicine for a long or short time, you should know that you may experience certain side effects, called withdrawal effects. These effects include sleep problems, headache, nausea, feeling anxious, diarrhea, flu-like symptoms, seizures, nervousness, depression, thoughts of harming yourself or suicidal thoughts, pain, sweating, and dizziness.
These effects may occur more frequently or severely if you have been taking this medicine for a longer period. If you experience withdrawal effects, you should see your doctor.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Very Common: may affect up to 1 in 10 people
Common: May affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very Rare: may affect up to 1 in 10,000 people
Frequency Not Known: cannot be estimated from the available data
Once you have finished a short or long-term treatment with pregabalin, you should know that you may experience certain adverse effects, called withdrawal effects (see "If you stop taking pregabalin").
If you experience swelling in the face or tongue, or if your skin turns red and has blisters or peeling, you should seek medical attention immediately.
Certain adverse effects, such as drowsiness, may be more frequent since patients with spinal cord injury may be taking other medications to treat, for example, pain or spasticity (stiff or rigid muscles), with similar adverse effects to those of this medicine, so the intensity of these effects may increase when taken together.
The following adverse reaction has been reported in post-marketing experience: difficulty breathing, shallow breathing.
Reporting of Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging or bottle, after CAD. The expiration date is the last day of the month indicated.
Store below 25°C.
Validity period once opened: 3 months.
Medicines should not be thrown away through the sewers or in the trash. Deposit the packaging and medicines you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Pregabalina Aristo:
Appearance of the Product and Package Contents
Pregabalina Aristo 20 mg/ml oral solution is a clear and colorless solution presented in a 500 ml high-density polyethylene bottle with a child-resistant HDPE screw cap, containing 473 ml of oral solution. 5 ml PP cylindrical syringe and HDPE plunger, graduated in 1.25, 2.5, 3.75, and 5 mL) with an LDPE adapter.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Aristo Pharma Iberia, S.L.
C/ Solana, 26
28850, Torrejón de Ardoz
Madrid, Spain
Manufacturer
Aristo Pharma GmbH
Wallenroder Straße 8-10,
13435 Berlin,
Germany
Or
Chanelle Medical Unlimited Company
Ida Business Park, Dublin Road
Loughrea, Co. H62 FH90 Galway
Ireland
Date of the Last Revision of this Prospectus: February 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).